Unifying heterogeneous expression data to predict targets for CAR-T cell therapy
Chimeric antigen receptor (CAR) T-cell therapy combines antigen-specific properties of monoclonal antibodies with the lytic capacity of T cells. An effective and safe CAR-T cell therapy strategy relies on identifying an antigen that has high expression and is tumor specific. This strategy has been s...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Taylor & Francis Group
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/bf7f740860484a71a617907389cbe23f |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|